Protein Linked to Fibrosis Progression Will Be Focus of Start-up’s Drive for Anti-fibrotic Therapy
Idiopathic Pulmonary Fibrosis, News
Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice. Enleofen Bio, a recently founded biotechnology start-up company, will try to move this finding ... Read more